Comments
Loading...

Nektar Therapeutics

NKTRNASDAQ
Logo brought to you by Benzinga Data
$1.26
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed

Nektar Therapeutics (NASDAQ:NKTR) Stock, Earnings Estimates, EPS, And Revenue

Nektar Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 5
EPS Estimate
$-0.210
Quarterly Revenue Estimate
$17.1M
Annual Revenue
(as of Jun 30)
$93.2M

Analyze the earnings history of Nektar Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Nektar Therapeutics (NKTR) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-08$-0.25$-0.20-25.0 %
Mar 20242024-05-09$-0.19$-0.190.00 %
Dec 20232024-03-04$-0.22$-0.21-4.76 %
Sep 20232023-11-07$-0.19$-0.205.00 %

Nektar Therapeutics (NKTR) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-08$23.49M$17.54M33.9 %
Mar 20242024-05-09$21.64M$15.34M41.1 %
Dec 20232024-03-04$23.89M$18.05M32.3 %
Sep 20232023-11-07$24.14M$21.31M13.3 %

FAQ

Q

When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?

A

Nektar Therapeutics (NKTR) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Nektar Therapeutics (NASDAQ:NKTR)?

A

The Actual EPS was $-0.25, which missed the estimate of $-0.20.

Q

What were Nektar Therapeutics’s (NASDAQ:NKTR) revenues?

A

The Actual Revenue was $23.5M, which beat the estimate of $17.5M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch